Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Clinical trial NCT05171166 · TERMINATED

Trial details

NCT number: NCT05171166
Sponsor: Peking University
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2021-12-24
Primary completion: 2025-10-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.